Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT intervalALLEN, Michael I; OLIVER, Stuart D; NEWGREEN, Margaret W et al.British journal of clinical pharmacology. 2002, Vol 53, Num 1, pp 59-65, issn 0306-5251Article

Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safetyPURKINS, Lynn; WOOD, Nolan; GREENHALGH, Katie et al.British journal of clinical pharmacology. Supplement. 2003, Vol 56, Num 1, pp 10-16, issn 0264-3774, 7 p.Article

Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteersIULIUCCI, John D; OLIVER, Stuart D; MORLEY, Steve et al.Journal of clinical pharmacology. 2001, Vol 41, Num 8, pp 870-879, issn 0091-2700Article

An Open-Label, Randomized, Single-Center, Two-Period, Phase I, Crossover Study of the Effect of Zibotentan (ZD4054) on the Pharmacokinetics of Midazolam in Healthy Male VolunteersTOMKINSON, Helen K; KEMP, John V; WOLLSEIFEN, Thomas et al.Clinical therapeutics. 2010, Vol 32, Num 7, pp 1372-1386, issn 0149-2918, 15 p.Article

Metabolism and disposition of the antihypertensive agent moxonidine in humansHE, Minxia M; ABRAHAM, Trent L; LINDSAY, Thomas J et al.Drug metabolism and disposition. 2003, Vol 31, Num 3, pp 334-342, issn 0090-9556, 9 p.Article